Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Lab on a Chip
|
February 6, 2013
Micro-volume wall-less immunoassays using patterned planar plates
Katherine R Kozak, Jianyong Wang, Melvin Lye, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degeneration
Kelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Blood
|
July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells
Chingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.
Blood
|
August 10, 2007
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
Wei Yu Lin, Qian Gong, Dhaya Seshasayee, et al.
JCI Insight
|
April 14, 2017
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN<b>α</b>-driven lupus nephritis
Arna Katewa, Yugang Wang, Jason A Hackney, et al.
Nature Chemical Biology
|
November 30, 2010
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A Di Paolo, Tao Huang, Mercedesz Balazs, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Lab on a Chip
|
February 6, 2013
Micro-volume wall-less immunoassays using patterned planar plates
Katherine R Kozak, Jianyong Wang, Melvin Lye, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degeneration
Kelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Blood
|
July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells
Chingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.
Blood
|
August 10, 2007
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
Wei Yu Lin, Qian Gong, Dhaya Seshasayee, et al.
JCI Insight
|
April 14, 2017
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN<b>α</b>-driven lupus nephritis
Arna Katewa, Yugang Wang, Jason A Hackney, et al.
Nature Chemical Biology
|
November 30, 2010
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A Di Paolo, Tao Huang, Mercedesz Balazs, et al.
Page
of 2